...from Advent Life Sciences, Gurnet Point Capital and Roche Venture Fund. Zikani, formerly known as Macrolide Pharmaceuticals Inc....

...in the facility,” Omega CSO Thomas McCauley told BioCentury. McCauley's previous positions include CSO of Macrolide Pharmaceuticals Inc....

...and develop antibiotics using Warp Drive's Genome Mining Platform. In April, Roche Ventures invested in Macrolide Pharmaceuticals Inc....

...and CFO of CRISPR-associated protein 9 (Cas9) company Intellia Therapeutics Inc. (NASDAQ:NTLA). Infectious disease company Macrolide Pharmaceuticals Inc....

...A round in 2015. Macrolide Pharmaceuticals Inc., Watertown, Mass. Mary Romeo Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator Harvard University Intarcia Therapeutics Inc. Macrolide Pharmaceuticals Inc....

...now CEO of Apnimed Inc. (Cambridge, Mass.). Mary Romeo Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator Harvard University Intarcia Therapeutics Inc. Macrolide Pharmaceuticals Inc....

...Selina Koch, Staff Writer A year after raising $22 million in a series A round, Macrolide Pharmaceuticals Inc....
...said. Companies and Institutions Mentioned Cempra Inc. (NASDAQ:CEMP), Chapel Hill, N.C. Harvard University, Cambridge, Mass. Macrolide Pharmaceuticals Inc....
...ring (not shown). Adapted with permission from Macrolide Pharmaceuticals Inc. From red to green Compounds generated by Macrolide Pharmaceuticals Inc....

...synthesis platform to create structurally diverse libraries of macrolide antibiotics LICENSING STATUS: Patented; licensed to Macrolide Pharmaceuticals Inc....

...fund's first investment was a $22 million series A round in March for antibiotics play Macrolide Pharmaceuticals Inc....

...N.C. Harvard University, Cambridge, Mass. Macrolide Pharmaceuticals Inc., Newton, Mass. Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH), Watertown, Mass. Sidebars Macrolide Pharmaceuticals Inc....